Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Vitiligo and alopecia areata may have similar causes despite their differences.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

Live imaging helps us understand skin immune responses and develop treatments.

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

High LH levels cause hair loss by damaging and aging hair follicles.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Hydrogel scaffolds can help wounds heal better and grow hair.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Immune system changes may contribute to female pattern hair loss.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Non-immune factors play a significant role in alopecia areata.